Myasthenia Gravis Is the Disease. FcRn Is the Target
Pharmaceutical Market Trend Insight, Experts Talk GLP-1 Competition and More | AMCP Annual 2025
ART Resistance Associated with Higher Hospital Costs Despite Lower Pharmacy-Related Expenses | AMCP Annual 2025
United Health Foundation Awards $7M in Grants to Improve Maternal, Infant Health
